BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37606168)

  • 1. METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.
    Chu S; Li Y; Wu B; Rong G; Hou Q; Zhou Q; Du D; Li Y
    Cell Transplant; 2023; 32():9636897231188300. PubMed ID: 37606168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3-mediated m
    Ji G; Wang X; Xi H
    Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma.
    Chen J; Wu Z; Zhang Y
    Int J Immunopathol Pharmacol; 2019; 33():2058738418820743. PubMed ID: 30791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
    Sun ZP; Tan ZG; Peng C; Yi WM
    J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA SNHG3 promotes glioma tumorigenesis by sponging miR-485-5p to upregulate LMX1B expression.
    Guo X; Zheng J; Yu MJ; Piao HZ; Zhao HY
    Kaohsiung J Med Sci; 2021 Oct; 37(10):851-862. PubMed ID: 34153159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
    Kang R; Yao DF; Xu GZ; Zhou YH
    Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-Mediated m
    Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
    Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG3 is responsible for the deterioration of colorectal carcinoma through regulating the miR-370-5p/EZH1 axis.
    Zhang Y; Li L; Lu KX; Yu LB; Meng J; Liu CY
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6131-6137. PubMed ID: 34661273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNRNPA2B1-mediated m
    Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
    J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA SNHG3 accelerates the proliferation and invasion of non-small cell lung cancer by downregulating miR-340-5p.
    He WW; Ma HT; Guo X; Wu WM; Gao EJ; Zhao YH
    J Biol Regul Homeost Agents; 2020; 34(6):2017-2027. PubMed ID: 33225676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
    Jiang H; Li X; Wang W; Dong H
    BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
    J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis related lncRNA SNHG3 / miR-139-5p / PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance.
    Yao Y; Chen X; Wang X; Li H; Zhu Y; Li X; Xiao Z; Zi T; Qin X; Zhao Y; Yang T; Wang L; Wu G; Fang X; Wu D
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129635. PubMed ID: 38266860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.
    Zhang M; Bai M; Wang L; Lu N; Wang J; Yan R; Cui M; Yan H; Zhang L
    Cancer Cell Int; 2021 Feb; 21(1):114. PubMed ID: 33596916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
    Long J; Pi X
    Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG3 Promotes Proliferation and Metastasis of Non-Small-Cell Lung Cancer Cells Through miR-515-5p/SUMO2 Axis.
    Li Y; Gao L; Zhang C; Meng J
    Technol Cancer Res Treat; 2021; 20():15330338211019376. PubMed ID: 34032148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
    Liu J; Jiang K
    J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
    Sun B; Han Y; Cai H; Huang H; Xuan Y
    Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.